Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Infection, Genetics and Evolution

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.meegid.2009.05.003PMID 19446658
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autologous Neutralizing Humoral Immunity and Evolution of the Viral Envelope in the Course of Subtype B Human Immunodeficiency Virus Type 1 Infection

  2008cited by this paper
• Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

  2008cited by this paper
• Frequent Intrapatient Recombination between Human Immunodeficiency Virus Type 1 R5 and X4 Envelopes: Implications for Coreceptor Switch

  2007cited by this paper
• APPLIED MIXED MODELS IN MEDICINE, 2ND ED.

  2007cited by this paper
• Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity

  2006cited by this paper
• Isolation of human immunodeficiency virus-type 1 (HIV-1) clones with biological and molecular properties of the primary isolate.

  2006cited by this paper
• The HIV coreceptor switch: a population dynamical perspective.

  2005cited by this paper
• V3: HIV's Switch-Hitter

  2005cited by this paper
• Phylodynamic Analysis of Human Immunodeficiency Virus Type 1 in Distinct Brain Compartments Provides a Model for the Neuropathogenesis of AIDS

  2005cited by this paper
• The V1/V2 Domain of gp120 Is a Global Regulator of the Sensitivity of Primary Human Immunodeficiency Virus Type 1 Isolates to Neutralization by Antibodies Commonly Induced upon Infection

  2004cited by this paper
• Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies

  2004influential reference
• Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.

  2004cited by this paper
• Predicting HIV-1 coreceptor usage with sequence analysis.

  2003cited by this paper
• Antibody neutralization and escape by HIV-1

  2003cited by this paper
• Improved Coreceptor Usage Prediction and GenotypicMonitoring of R5-to-X4 Transition by Motif Analysis of HumanImmunodeficiency Virus Type 1 env V3 LoopSequences

  2003influential reference
• HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use

  2003cited by this paper
• Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression

  2002cited by this paper
• Cooperation of the V1/V2 and V3 Domains of Human Immunodeficiency Virus Type 1 gp120 for Interaction with the CXCR4 Receptor

  2001cited by this paper
• Determination of Coreceptor Usage of Human Immunodeficiency Virus Type 1 from Patient Plasma Samples by Using a Recombinant Phenotypic Assay

  2001influential reference
• Length Variation of Glycoprotein 120 V2 Region in Relation to Biological Phenotypes and Coreceptor Usage of Primary HIV Type 1 Isolates

  2001influential reference
• Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1.

  2001cited by this paper
• N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization*

  2001cited by this paper
• Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks.

  2001cited by this paper
• N-Linked Glycosylation Sites Adjacent to and within the V1/V2 and the V3 Loops of Dualtropic Human Immunodeficiency Virus Type 1 Isolate DH12 gp120 Affect Coreceptor Usage and Cellular Tropism

  2001cited by this paper
• Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

  2000cited by this paper
• Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.

  2000cited by this paper
• Applied Mixed Models in Medicine

  2000cited by this paper
• The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency.

  1998cited by this paper
• MODELTEST: testing the model of DNA substitution

  1998cited by this paper
• The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

  1997influential reference
• HIV entry and tropism: the chemokine receptor connection.

  1997cited by this paper
• Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals

  1997cited by this paper
• Regulation of N-linked core glycosylation: use of a site-directed mutagenesis approach to identify Asn-Xaa-Ser/Thr sequons that are poor oligosaccharide acceptors.

  1997cited by this paper
• In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression

  1997cited by this paper
• Regulation of N-linked core glycosylation : use of a site-directed mutagenesis approach to identify AsnXaaSer AsnXaaSer AsnXaaSer XaaSer XaaSer / Thr sequons that are poor oligosaccharide acceptors

  1997cited by this paper
• HIV entry and tropism: the chemokine receptor connection.

  1997cited by this paper
• In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression

  1997influential reference
• Identification of a major co-receptor for primary isolates of HIV-1

  1996cited by this paper
• Molecular Epidemiology and MT-2 Cell Tropism of Russian HIV Type 1 Variants

  1996cited by this paper
• Identification of Breakpoints in Intergenotypic Recombinants of HIV Type 1 by Bootscanning

  1995cited by this paper
• Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR

  1995influential reference
• MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance.

  1994cited by this paper
• Relation of phenotype evolution of HIV-1 to envelope V2 configuration.

  1993cited by this paper
• Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution

  1992influential reference
• Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

  1992influential reference
• The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins.

  1974cited by this paper

• HIV-1 Entry Mechanisms: Protein-Host Receptor Interactions and Membrane Fusion Dynamics.

  2025cites this paper
• Impact of INSTI on a Drug-Resistant Mutation (S68S Insertion) in a Patient Infected with HIV-1 CRF06_cpx

  2025cites this paper
• Korean Red Ginseng slows coreceptor switch in HIV-1 infected patients

  2022cites this paper
• CView: A network based tool for enhanced alignment visualization

  2022cites this paper
• Unique profile of predominant CCR5-tropic in CRF07_BC HIV-1 infections and discovery of an unusual CXCR4-tropic strain

  2022cites this paper
• Intra-Patient Evolution of HIV-2 Molecular Properties

  2022cites this paper
• High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil

  2021cites this paper
• Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure

  2021cites this paper
• Variations in Env at Amino Acids 328 and 330 Affect HIV-1 Replicative Fitness and Entry Inhibitor Sensitivity.

  2021cites this paper
• HIV-1 Entry and Membrane Fusion Inhibitors

  2021cites this paper
• Intrahost evolution of the HIV-2 capsid correlates with progression to AIDS

  2021cites this paper
• HIV-1 subtype C predicted co-receptor tropism in Africa: an individual sequence level meta-analysis

  2020cites this paper
• New Diagnostic Approaches to Viral Sexually Transmitted Infections

  2020cites this paper
• Sexually Transmitted Infections: Advances in Understanding and Management

  2020cites this paper
• Molecular Mechanism of HIV-1 Entry.

  2019cites this paper
• HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies

  2018cites this paper
• Low-Bias RNA Sequencing of the HIV-2 Genome from Blood Plasma

  2018cites this paper
• Protein structural disorder of the envelope V3 loop contributes to the switch in human immunodeficiency virus type 1 cell tropism

  2017cites this paper
• Mechanistic Studies of Viral Entry: An Overview of Dendrimer‐Based Microbicides As Entry Inhibitors Against Both HIV and HSV‐2 Overlapped Infections

  2017cites this paper
• TARGETING THE SEMEN DERIVED AMYLOIDS TO CONTROL HIV TRANSMISSION: PERSPECTIVES AND CHALLENGES

  2016cites this paper
• Buffering deleterious polymorphisms in highly constrained parts of HIV-1 envelope by flexible regions

  2016cites this paper
• High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia

  2016cites this paper
• The potential of broadly neutralizing HIV antibodies to function as microbicides

  2016cites this paper
• Cyclic Selection in HIV-1 Tropism: Microevolution That Is Going Nowhere

  2015cites this paper
• Cyclic Selection in HIV – 1 Tropism : Microevolution T hat I s Going Nowhere

  2015cites this paper
• HIV‐1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy

  2015cites this paper
• The evolution of HIV-1 interactions with coreceptors and mannose C-type lectin receptors.

  2015cites this paper
• Progress in studies of structure, mechanism and antagonists interaction of GPCR co-receptors for HIV.

  2014cites this paper
• Evolution of HIV-1 Coreceptor Usage and Coreceptor Switching During Pregnancy

  2014cites this paper
• DETERMINATION OF VIRAL TROPISM BY GENOTYPING AND PHENOTYPING ASSAYS IN BRAZILIAN HIV-1-INFECTED PATIENTS

  2014cites this paper
• High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.

  2013cites this paper
• Frequency and Predictors of HIV-1 Co-receptor Switch in Treatment Naive Patients

  2013cites this paper
• Pathogenesis of HIV Infection

  2013cites this paper
• Is the Rate of CD4 Cell Decline Changing Over Time in Antiretroviral-Naïve Patients?

  2013cites this paper
• Analysis of antibody neutralization specificities in human immunodeficiency virus type 2 infection

  2013cites this paper
• Ultra‐deep sequencing reveals hidden HIV‐1 minority lineages and shifts of viral population between the main cellular reservoirs of the infection after therapy interruption

  2012cites this paper
• Discordance in HIV‐1 Co‐receptor use prediction by different genotypic algorithms and phenotype assay: Intermediate profile in relation to concordant predictions

  2012cites this paper
• Coreceptor Usage in HIV Infection

  2012cites this paper
• Ultra-deep characterization of viral quasispecies in HIV infection

  2012cites this paper
• HIV-1 Co-Receptor Usage Based on V3 Loop Sequence Analysis: Preferential Suppression of CXCR4 Virus Post HAART?

  2011cites this paper
• Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance

  2011cites this paper
• Impact of Mutations Outside the V3 Region on Coreceptor Tropism Phenotypically Assessed in Patients Infected with HIV-1 Subtype B

  2011cites this paper
• Genotypic Analysis of Human Immunodeficiency Virus Type 1 env V3 Loop Sequences: Bioinformatics Prediction of Coreceptor Usage Among 28 Infected Mother–Infant Pairs in a Drug-Naive Population

  2011cites this paper
• Determinação do tropismo do HIV-1 pelos correceptores CCR5 e CXCR4 pelo uso de ferramentas de bioinformática.

  2010cites this paper
• Manifestações orais associadas ao HIV após 30 anos de epidemia no Brasil

  2010cites this paper
• AID-mediated somatic hypermutation for generation of viral envelope protein diversity in patient-specific therapeutic HIV vaccines based on induction of neutralizing antibodies.

  2010cites this paper